Search results
Pages
-
- T cells engaging the conserved Mhc class ib Molecule Qa-1(b) with TaP-independent Peptides are semi-invariant lymphocytes
-
- The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer
-
- Tumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial
-
- HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
-
- The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
-
- CD4(+) T Cell and NK Cell Interplay Key to Regression of MHC Class I-low Tumors upon TLR7/8 Agonist Therapy
-
- Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors
-
- The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization
-
- IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
-
- Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
-
- Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4(+) and CD8(+) T Cell Responses against Mouse Cytomegalovirus Infection
-
- Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
-
- Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFN gamma- and TNF alpha-Mediated Antiproliferative Effects and Necroptosis